... Thornicroft G, Coffey M, Dunn G: A brief mental health outcomescale-reliability and validity of the Global Assessment of Functioning(GAF). Br J Psychiatry 1995, 166:654-659.22. Taylor DM, Young CL, ... At the end of the study, the general trend wastoward higher doses. The final dose, based on allpatients in the study at 24 months, was 25 mg in 20%to 35% of all patients and 50 mg in 40.2% of ... Eerdekens M, Lindenmayer JP, Keith SJ, Lesem M, Karcher K: Long-acting injectable risperidone: efficacy and safety of the first long-actingatypical antipsychotic. Am J Psychiatry2003, 160:1125-1132.16....